GlassScriptPhysician profile
Aashish Kabra
NPI 1518226794
$50,105.66
in general payments reported to CMS, 2019-2025
31 companies · $22K in 2025
The $22K reported for 2025 was more than what 96% of Urology providers received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,568 · 2020: $86.33 · 2021: $389 · 2022: $1,593 · 2023: $13K · 2024: $12K · 2025: $22K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $35K · Travel and Lodging: $7,917 · Food and Beverage: $3,077.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $35,475.00 |
| Travel and Lodging | $7,917.13 |
| Food and Beverage | $3,077.32 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Procept Biorobotics Corporation | $46,541.65 | 2022-2025 | Aquabeam Robotic System, Aquabeam System |
| Boston Scientific Corporation | $1,497.40 | 2019-2025 | Axonics, Solyx Sis System |
| Teleflex LLC | $268.22 | 2022-2025 | Urolift, Barrigel |
| Myriad Genetic Laboratories, INC. | $243.85 | 2021-2024 | Prolaris |
| Neotract INC. | $228.00 | 2019 | |
| Astellas Pharma US INC | $163.81 | 2019-2023 | Myrbetriq |
| Intuitive Surgical, INC. | $132.60 | 2021-2022 | |
| Axonics, INC. | $117.19 | 2021-2024 | Bulkamid, Axonics |
| Medtronic, INC. | $117.11 | 2023-2024 | Interstim |
| Laborie Medical Technologies Corp. | $94.91 | 2021-2023 | |
| Blue Earth Diagnostics | $84.65 | 2025 | Posluma |
| Endo Pharmaceuticals INC. | $75.70 | 2021-2023 | Xiaflex, Aveed, Edex |
| Calyxo, INC. | $57.50 | 2024 | Cvac Aspiration System |
| Dornier Medtech America, INC | $49.03 | 2024 | Dornier Medtech |
| Histosonics, INC. | $47.84 | 2025 |
Show all 31 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Olympus America INC. | $42.99 | 2023-2024 | Itind System, Cysto-Nephro Videoscope |
| Myovant Sciences INC. | $40.63 | 2021 | |
| Fujifilm Healthcare Americas Corporation | $39.69 | 2022 | |
| Immunitybio, INC. | $28.56 | 2024 | |
| Srs Medical Systems, INC. | $28.21 | 2020-2021 | |
| Allergan, INC. | $25.49 | 2021 | |
| Angiodynamics, INC. | $25.43 | 2024 | Nanoknife |
| Photocure INC | $21.50 | 2021 | |
| Sumitomo Pharma America, INC. | $19.51 | 2024 | Gemtesa |
| Clarus Therapeutics INC. | $19.23 | 2021 | |
| Sunovion Pharmaceuticals INC. | $18.83 | 2022 | |
| Coloplast Corp | $17.57 | 2024 | |
| Ambu INC. | $16.98 | 2020 | |
| Urogen Pharma, INC. | $14.08 | 2021 | |
| Progenics Pharmaceuticals, INC. | $13.78 | 2023 | Pylarify |
| Valencia Technologies Corporation | $13.72 | 2022-2023 | Ecoin Device Kit |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Aashish Kabra listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.